Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 14 de 14
Filtrer
Plus de filtres










Base de données
Gamme d'année
2.
Ann Oncol ; 33(3): 340-346, 2022 03.
Article de Anglais | MEDLINE | ID: mdl-34958894

RÉSUMÉ

BACKGROUND: Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of antineoplastic systemic therapies can result in less robust antibody titers following vaccination and possible risk of breakthrough infection. As clinical trials evaluating COVID-19 vaccines largely excluded patients with a history of cancer and those on active immunosuppression (including chemotherapy), limited evidence is available to inform the clinical efficacy of COVID-19 vaccination across the spectrum of patients with cancer. PATIENTS AND METHODS: We describe the clinical features of patients with cancer who developed symptomatic COVID-19 following vaccination and compare weighted outcomes with those of contemporary unvaccinated patients, after adjustment for confounders, using data from the multi-institutional COVID-19 and Cancer Consortium (CCC19). RESULTS: Patients with cancer who develop COVID-19 following vaccination have substantial comorbidities and can present with severe and even lethal infection. Patients harboring hematologic malignancies are over-represented among vaccinated patients with cancer who develop symptomatic COVID-19. CONCLUSIONS: Vaccination against COVID-19 remains an essential strategy in protecting vulnerable populations, including patients with cancer. Patients with cancer who develop breakthrough infection despite full vaccination, however, remain at risk of severe outcomes. A multilayered public health mitigation approach that includes vaccination of close contacts, boosters, social distancing, and mask-wearing should be continued for the foreseeable future.


Sujet(s)
COVID-19 , Tumeurs , Vaccins contre la COVID-19 , Humains , Tumeurs/complications , SARS-CoV-2 , Vaccination
3.
Clin Oncol (R Coll Radiol) ; 34(2): 135-140, 2022 02.
Article de Anglais | MEDLINE | ID: mdl-34887151

RÉSUMÉ

Clinical informatics is a young, diverse and rapidly growing field. We asked eight clinical informaticians from a variety of oncology specialties, training pathways and careers for personal narratives to illustrate the wide spectrum of clinical informatics careers. Primary clinical specialties included radiation oncology, medical/haematology oncology and palliative care. Training pathways included fellowship, non-fellowship formal training and informal training. Careers included clinical care, research, operations and industry. We summarised common themes and advice for trainees. We hope to raise awareness of clinical informatics among trainees and oncologists to reveal new career opportunities and to avoid inadvertently taking clinical informatics and informaticians for granted.


Sujet(s)
Bourses d'études et bourses universitaires , Informatique médicale , Humains , Oncologie médicale
4.
Ann Oncol ; 29(11): 2266-2267, 2018 11 01.
Article de Anglais | MEDLINE | ID: mdl-30215682
5.
Diabet Med ; 35(10): 1448-1456, 2018 10.
Article de Anglais | MEDLINE | ID: mdl-29888811

RÉSUMÉ

AIM: To evaluate the PAQ® (CeQur SA, Horw, Switzerland), a wearable 3-day insulin delivery device that provides set basal rates and bolus insulin on demand, in people with Type 2 diabetes. METHOD: Adults with Type 2 diabetes with HbA1c concentrations ≥53 and ≤97 mmol/mol (7.0 and 11.0%) while treated with ≥2 insulin injections/day were enrolled in two single-arm studies comprising three periods: a baseline (insulin injections), a transition and a PAQ treatment period (12 weeks). Endpoints included HbA1c , seven-point self-monitored blood glucose, total daily dose of insulin and body weight. Safety was assessed according to examination, hypoglycaemic episodes and adverse device effects. RESULTS: A total of 28 adults were enrolled (age 63 ± 7 years, 86% men, BMI 32.3 ± 4.3kg/m2 , Type 2 diabetes duration 17 ± 8 years, HbA1c 70 ± 12 mmol/mol (8.6 ± 1.1%), total daily insulin dose 58.7 ± 20.7 U), of whom 24 completed the studies. When transitioned to PAQ, 75% of participants continued on the first basal rate selected. After 12 weeks of PAQ wear, significant improvements from baseline were seen [HbA1c -16 ± 9 mmol/mol (95% CI -20, -12) or -1.5 ± 0.9% (95% CI -1.8, -1.1) P<0.0001], and at all seven self-monitored blood glucose readings time points (P ≤0.03). Total daily insulin dose increased by 12.1 ± 19.5 U (95% CI 3.9, 20.4; P=0.0058), the number of meal time boluses increased by 0.9 ± 1.5/day (95% CI 0.3, 1.5; P=0.0081) and body weight remained stable. Six participants had mild to moderate catheter site reactions and one mild skin irritation occurred. No participant experienced severe hypoglycaemia. CONCLUSIONS: Adults with Type 2 diabetes were safely transitioned from insulin injections to the PAQ and had significantly improved glycaemic control and treatment satisfaction with insulin therapy. (ClinicalTrials.gov identifiers: NCT02158078 & NCT02419859).


Sujet(s)
Glycémie/effets des médicaments et des substances chimiques , Diabète de type 2/traitement médicamenteux , Pompes à insuline , Insuline/administration et posologie , Satisfaction des patients , Dispositifs électroniques portables , Adulte , Sujet âgé , Glycémie/analyse , Glycémie/métabolisme , Autosurveillance glycémique/instrumentation , Diabète de type 2/sang , Diabète de type 2/psychologie , Femelle , Humains , Insuline/effets indésirables , Mâle , Adulte d'âge moyen , Projets pilotes , Facteurs temps
6.
Yearb Med Inform ; 26(1): 139-147, 2017 Aug.
Article de Anglais | MEDLINE | ID: mdl-29063555

RÉSUMÉ

Objectives: Electronic health records (EHRs) have increasingly emerged as a powerful source of clinical data that can be leveraged for reuse in research and in modular health apps that integrate into diverse health information technologies. A key challenge to these use cases is representing the knowledge contained within data from different EHR systems in a uniform fashion. Method: We reviewed several recent studies covering the knowledge representation in the common data models for the Observational Medical Outcomes Partnership (OMOP) and its Observational Health Data Sciences and Informatics program, and the United States Patient Centered Outcomes Research Network (PCORNet). We also reviewed the Health Level 7 Fast Healthcare Interoperability Resource standard supporting app-like programs that can be used across multiple EHR and research systems. Results: There has been a recent growth in high-impact efforts to support quality-assured and standardized clinical data sharing across different institutions and EHR systems. We focused on three major efforts as part of a larger landscape moving towards shareable, transportable, and computable clinical data. Conclusion: The growth in approaches to developing common data models to support interoperable knowledge representation portends an increasing availability of high-quality clinical data in support of research. Building on these efforts will allow a future whereby significant portions of the populations in the world may be able to share their data for research.


Sujet(s)
Éléments de données communs , Interopérabilité des informations de santé , Systèmes informatisés de dossiers médicaux/normes , Health Level Seven (organisme) , Informatique médicale
8.
J Fish Biol ; 90(1): 80-92, 2017 Jan.
Article de Anglais | MEDLINE | ID: mdl-27861861

RÉSUMÉ

The objective of this study was to characterize the genetics of second generation (F2 ) koi Cyprinus carpio × goldfish Carassius auratus hybrids. Spermatozoa produced by a novel, fertile F1 male were found to be diploid by flow-cytometric analysis. Backcross (F1 female × C. carpio male and C. carpio female × F1 male) juveniles were triploid, confirming that female and male F1 hybrids both produced diploid gametes. The vast majority of surviving F2 juveniles was diploid and small proportions were aneuploid (2·1n-2·3n and 3·1n-3·9n), triploid (3n) and tetraploid (4n). Microsatellite genotyping showed that F2 diploids repeated either the complete maternal or the complete paternal genotype. Fish with the maternal genotype were female and fish with the paternal genotype were male. This demonstrates that F2 diploids were the result of spontaneous gynogenesis and spontaneous androgenesis. Analysis of microsatellite inheritance and the sex ratio in F2 crosses showed that spontaneous gynogenesis and androgenesis did not always occur in equal proportions. One cross was found to have an approximate equal number of androgenetic and gynogenetic offspring while in several other crosses spontaneous androgenesis was found to occur more frequently than spontaneous gynogenesis.


Sujet(s)
Carpes (poisson)/physiologie , Polyploïdie , Processus de détermination du sexe/génétique , Animaux , Sélection , Carpes (poisson)/génétique , Diploïdie , Femelle , Génotype , Cellules germinales , Poisson rouge/génétique , Mâle , Répétitions microsatellites/génétique , Triploïdie
9.
Virology ; 276(1): 44-51, 2000 Oct 10.
Article de Anglais | MEDLINE | ID: mdl-11021993

RÉSUMÉ

Cyclooxygenase (COX) is the key enzyme in the conversion of arachidonic acid to prostaglandins. COX has two isoforms: COX-1, the constitutively expressed form, and COX-2, the inducible form. Prostaglandins are mediators of many critical physiological and inflammatory responses, but little is known about their roles during a viral infection in the central nervous system (CNS). We used non-selective inhibitors of COX, aspirin and indomethacin, and a selective antagonist of COX-2, celecoxib, to study the role of prostaglandins in Vesicular Stomatitis Virus (VSV) induced encephalitis. We found that the inhibition of COX antagonizes VSV propagation both in vitro and in vivo. In addition, aspirin and celecoxib both prevented the disruption of the blood brain barrier in VSV-infected mice. In vitro experiments showed that the effect of COX inhibition was at least partially mediated by increased production of Nitric Oxide (NO), a molecule known to inhibit VSV replication. When NO production was inhibited by N(omega)-nitro-L-methyl-arginine-ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, the difference in viral titer between aspirin (or celecoxib)-treated and the control cells was abolished. VSV-infected mice treated with celecoxib expressed more NOS-1 and produced more NO in their CNS compared to the controls. Our data suggest that the product(s) of COX have antagonistic effect(s) on NO production in the mouse CNS.


Sujet(s)
Anti-inflammatoires non stéroïdiens/pharmacologie , Encéphale/virologie , Virus de la stomatite vésiculeuse de type Indiana/effets des médicaments et des substances chimiques , Animaux , Cyclooxygenase 2 , Dinoprostone/pharmacologie , Isoenzymes/physiologie , Mâle , Souris , Souris de lignée BALB C , L-NAME/pharmacologie , Monoxyde d'azote/biosynthèse , Nitric oxide synthase/physiologie , Nitric oxide synthase type I , Prostaglandin-endoperoxide synthases/physiologie , Virus de la stomatite vésiculeuse de type Indiana/physiologie , Réplication virale/effets des médicaments et des substances chimiques
10.
JSLS ; 2(3): 235-8, 1998.
Article de Anglais | MEDLINE | ID: mdl-9876745

RÉSUMÉ

PURPOSE: To review the effect of non-gynecologic laparoscopic procedures performed during the second and third trimesters of pregnancy on pregnancy outcome. MATERIALS AND METHODS: A review of the patient log for the antenatal obstetrical unit was used to identify the patients in this series from January 1, 1997 to December 31, 1997. Medical records were then analyzed to identify estimated gestational age at surgery and delivery, type of delivery, use of tocolysis, and complications from surgery. RESULTS: Nine patients were identified as having non-gynecologic laparoscopic surgery (without conversion to laparotomy) during the second or third trimester of pregnancy. The median estimated gestational age at surgery was 25 weeks (mean 24 weeks). The most common procedure performed was laparoscopic cholecystectomy (6 patients). Five patients received tocolysis after the initial procedure. All patients delivered at greater than or equal to 37 weeks estimated gestational age (median 38 weeks). No infants were admitted to the neonatal intensive care unit. CONCLUSIONS: Laparoscopic procedures appear safe in second and third trimester pregnancy. In this study, laparoscopic cholecystectomies were performed as late as 34 weeks estimated gestational age without any adverse effects on pregnancy outcome.


Sujet(s)
Appendicite/chirurgie , Cholécystite/chirurgie , Laparoscopie/méthodes , Complications de la grossesse/chirurgie , Issue de la grossesse , Adulte , Appendicite/diagnostic , Cholécystite/diagnostic , Femelle , Études de suivi , Âge gestationnel , Humains , Grossesse , Complications de la grossesse/diagnostic , Deuxième trimestre de grossesse , Troisième trimestre de grossesse , Pronostic , Enregistrements , Études rétrospectives , Tocolyse/méthodes
11.
Science ; 191(4223): 179-81, 1976 Jan 16.
Article de Anglais | MEDLINE | ID: mdl-1246603

RÉSUMÉ

Photochemical air pollution resulting from primary emissions in the New York City metropolitan area is transported by prevailing winds on a 300-kilometer northeast trajectory through Connecticut and as far as northeastern Massachusetts. As a result, southwestern Connecticut has the highest ozone concentrations in the region and there is a substantial increase in ozone concentrations in Massachusetts. The ozone concentrations of air entering the New York City metropolitan area are often already above the federal standard of 0.08 part per million, but the concentration distribution is well below concentration distributions at downwind sites in Connecticut.


Sujet(s)
Pollution de l'air/analyse , Ozone/analyse , Connecticut , Massachusetts , New Jersey , État de New York
13.
Science ; 186(4168): 1037-8, 1974 Dec 13.
Article de Anglais | MEDLINE | ID: mdl-17843058

RÉSUMÉ

Concentration distributions of air contaminants and meteorological variables in New Jersey and New York for workdays (Mondays through Fridays, omitting holidays) and Sundays are compared by means of quantile-quantile plots. The ozone distributions are slightly higher on Sundays, and the primary pollutant distributions are lower. These results raise serious questions about the validity of current concepts underlying ozone reduction in urban atmospheres.

14.
Science ; 186(4160): 257-9, 1974 Oct 18.
Article de Anglais | MEDLINE | ID: mdl-17782020

RÉSUMÉ

The concentrations of ozone at nine measurements sites in New Jersey and New York during the period 1 May through 30 September 1973 have been examined. Daily fluctuations in the ozone concentrations at any two sites are highly correlated. The concentrations are lower with low levels of solar radiation and also with high wind speed. The average ozone concentration shows only minor differences between weekdays and weekends, despite markedly different traffic patterns.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...